Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 13 de 13
Filter
Add more filters










Publication year range
1.
PLoS One ; 8(1): e53913, 2013.
Article in English | MEDLINE | ID: mdl-23326534

ABSTRACT

Hydrogen (H(2)) acts as a therapeutic antioxidant. However, there are few reports on H(2) function in other capacities in diabetes mellitus (DM). Therefore, in this study, we investigated the role of H(2) in glucose transport by studying cultured mouse C2C12 cells and human hepatoma Hep-G2 cells in vitro, in addition to three types of diabetic mice [Streptozotocin (STZ)-induced type 1 diabetic mice, high-fat diet-induced type 2 diabetic mice, and genetically diabetic db/db mice] in vivo. The results show that H(2) promoted 2-[(14)C]-deoxy-d-glucose (2-DG) uptake into C2C12 cells via the translocation of glucose transporter Glut4 through activation of phosphatidylinositol-3-OH kinase (PI3K), protein kinase C (PKC), and AMP-activated protein kinase (AMPK), although it did not stimulate the translocation of Glut2 in Hep G2 cells. H(2) significantly increased skeletal muscle membrane Glut4 expression and markedly improved glycemic control in STZ-induced type 1 diabetic mice after chronic intraperitoneal (i.p.) and oral (p.o.) administration. However, long-term p.o. administration of H(2) had least effect on the obese and non-insulin-dependent type 2 diabetes mouse models. Our study demonstrates that H(2) exerts metabolic effects similar to those of insulin and may be a novel therapeutic alternative to insulin in type 1 diabetes mellitus that can be administered orally.


Subject(s)
Diabetes Mellitus, Experimental/drug therapy , Diabetes Mellitus, Type 1/drug therapy , Diabetes Mellitus, Type 2/drug therapy , Hydrogen/administration & dosage , Muscle, Skeletal/drug effects , AMP-Activated Protein Kinase Kinases , Animals , Blood Glucose/drug effects , Cricetinae , Diabetes Mellitus, Experimental/metabolism , Diabetes Mellitus, Experimental/physiopathology , Diabetes Mellitus, Type 1/genetics , Diabetes Mellitus, Type 1/metabolism , Diabetes Mellitus, Type 2/metabolism , Diabetes Mellitus, Type 2/physiopathology , Diet, High-Fat , Disease Models, Animal , Glucose/metabolism , Glucose Transporter Type 4/metabolism , Hep G2 Cells , Humans , Mice , Muscle, Skeletal/metabolism , Phosphatidylinositol 3-Kinases/metabolism , Protein Kinase C/metabolism , Protein Kinases/metabolism
2.
Circ J ; 76(6): 1423-9, 2012.
Article in English | MEDLINE | ID: mdl-22447011

ABSTRACT

BACKGROUND: Ghrelin is an acylated peptide hormone mainly secreted from the stomach. When administrated externally it modulates vascular tone mainly through the regulation of autonomic nerve activity. However, the effects of blood pressure (BP) on the production and secretion of ghrelin remain to be clarified. METHODS AND RESULTS: We examined the stomach and plasma levels of ghrelin in spontaneously hypertensive (SHR) and Wistar-Kyoto (WKY) rats after a 4-week-intervention with antihypertensive agents (candesartan-cilexetil [ARB], doxazosin [DZN], metoprolol [MP], reserpine [RES]) to clarify the influence of BP on the secretion of ghrelin. The effect of these agents on ghrelin production and secretion were examined by comparing vehicle-treated controls (WKY-Intact, SHR-Intact). Treatment with the 4 antihypertensive drugs all yielded a significant decline in systolic BP in both SHR and WKY. Under these conditions, significantly lower levels of stomach and plasma ghrelin were detected in WKY treated with ARB (P<0.05), DZN (P<0.05), MP (P<0.05) and RES (P<0.05) compared with WKY-Intact, whereas no significant change in the ghrelin levels in the stomach and plasma were detected in SHR under the same treatments. CONCLUSIONS: The findings imply that the production and secretion of ghrelin are controlled by the ambient vascular tone and vice versa in normotensive WKY. This inter-relationship between ghrelin and BP seems to be disrupted in SHR.


Subject(s)
Blood Pressure/drug effects , Ghrelin/blood , Hypertension/drug therapy , Stomach/drug effects , Adrenergic alpha-1 Receptor Antagonists/pharmacology , Adrenergic beta-1 Receptor Antagonists/pharmacology , Angiotensin II Type 1 Receptor Blockers/pharmacology , Animals , Antihypertensive Agents/pharmacology , Benzimidazoles/pharmacology , Biphenyl Compounds/pharmacology , Disease Models, Animal , Doxazosin/pharmacology , Gastric Mucosa/metabolism , Gene Expression Regulation , Ghrelin/genetics , Hypertension/blood , Hypertension/physiopathology , Insulin Resistance , Male , Metoprolol/pharmacology , Norepinephrine/blood , RNA, Messenger/metabolism , Rats , Rats, Inbred SHR , Rats, Inbred WKY , Reserpine/pharmacology , Tetrazoles/pharmacology , Time Factors , Vasodilator Agents/pharmacology
3.
Int J Mol Med ; 27(4): 497-502, 2011 Apr.
Article in English | MEDLINE | ID: mdl-21318217

ABSTRACT

Hepatocyte growth factor (HGF) is a multifunctional growth factor with mitogenic, anti-apoptotic and anti-fibrotic activities. In this study, we investigated the effect of administration of recombinant human HGF on pulmonary arterial hypertension. Pulmonary arterial hypertension was induced in rats by a single injection of monocrotaline (MCT) and recombinant human HGF (0.12 mg/day) was administered into the right ventricle cavity using osmotic pumps, which were implanted subcutaneously 21 days after MCT injection. Continuous intravenous delivery of recombinant human HGF for 14 days led to prolonged survival of animals suffering from severe MCT-induced pulmonary arterial hypertension. Although a bolus injection of recombinant human HGF did not affect pulmonary arterial pressure, a 14-day administration of recombinant human HGF attenuated the inflammatory cell infiltrate, matrix accumulation and vascular medial thickening. As a consequence, the pulmonary lumen was enlarged and the pulmonary arterial pressure was significantly reduced. Additionally, continuous administration of recombinant human HGF suppressed lung tissue expression of platelet-derived growth factor, which plays an important role in the development of pulmonary arterial hypertension. These results indicate that recombinant human HGF possibly has a great potential for improving symptoms and altering the clinical course of pulmonary arterial hypertension.


Subject(s)
Hemodynamics/drug effects , Hepatocyte Growth Factor/pharmacology , Hypertension, Pulmonary/physiopathology , Recombinant Proteins/pharmacology , 6-Ketoprostaglandin F1 alpha/blood , Animals , Blood Pressure/drug effects , C-Reactive Protein/analysis , Constriction, Pathologic/drug therapy , Disease Models, Animal , Familial Primary Pulmonary Hypertension , Gene Expression Regulation/drug effects , Hepatocyte Growth Factor/therapeutic use , Humans , Hypertension, Pulmonary/drug therapy , Hypertension, Pulmonary/pathology , Male , Monocrotaline/adverse effects , Monocrotaline/pharmacology , Platelet-Derived Growth Factor/metabolism , Pulmonary Artery/drug effects , Pulmonary Artery/physiopathology , Rats , Rats, Wistar , Recombinant Proteins/therapeutic use , Survival Analysis
4.
Exp Anim ; 56(5): 369-73, 2007 Oct.
Article in English | MEDLINE | ID: mdl-18075197

ABSTRACT

Skin morphology of the Clawn miniature pig (CMP) was investigated at the axilla, medial thigh, back and loin. The mean thickness of the epidermis (excluding the corneal layer), the mean number of layers of keratinocytes comprising the epidermis and the mean height of keratinocytes were assessed morphometrically. When observed under a light microscope, the skin of the CMP resembled human skin. Morphometrically, skin from the back and loin of the CMP most resembles human skin. Electron microscopic observations revealed sparse but typical Birbeck granules in the epidermal Langerhans cells of the CMP. The results of the present study indicate that CMP skin is potentially useful as a model for human skin.


Subject(s)
Skin/anatomy & histology , Swine, Miniature/anatomy & histology , Animals , Epidermal Cells , Epidermis/anatomy & histology , Female , Humans , Keratinocytes/cytology , Langerhans Cells/cytology , Male , Skin/cytology , Skin/ultrastructure , Swine
5.
Exp Anim ; 56(5): 375-8, 2007 Oct.
Article in English | MEDLINE | ID: mdl-18075198

ABSTRACT

The characteristics and gender differences of the pulmonary hemodynamic parameters of 16 Clawn miniature pigs were examined and the data were compared with reports concerning dogs and other pig species. The pulmonary systolic, diastolic and mean arterial blood pressures of the mini-pig were slightly higher than those of the dog, respectively, but both the right atrial pressure and pulmonary capillary wedge pressure were within the normal physiological ranges of the dog. Concerning gender differences in hemodynamic parameters of the mini-pig, the female values, except the right atrial pressure, were slightly higher than those of the male, but no significant differences were recognized. The present study results will help pulmonary researchers understand the differences between Clawn miniature pigs and dogs for accurate analysis of experimental results.


Subject(s)
Hemodynamics/physiology , Pulmonary Circulation/physiology , Swine, Miniature/physiology , Animals , Atrial Function , Blood Pressure/physiology , Diastole/physiology , Dogs , Female , Male , Pulmonary Wedge Pressure/physiology , Sex Factors , Swine , Systole/physiology
6.
Xenotransplantation ; 14(6): 636-41, 2007 Nov.
Article in English | MEDLINE | ID: mdl-17991152

ABSTRACT

High mobility group box-1 (HMGB1) protein, primarily from the nucleus, is released into the extracellular milieu either passively by necrotic or damaged cells, or actively by secretion from monocytes/macrophages. Extracellular HMGB1 acts as a potent inflammatory stimulator by promoting cytokine (for example, tumor necrosis factor-alpha) production, and also has pro-coagulant activity. The signaling pathway initiated by receptor for advanced glycation end-product (RAGE), which is the HMGB1 receptor, also induces complement activation. Recent studies have implicated HMGB1 in acute cardiac allograft rejection, and have identified infiltrating T cells and other damaged cells as its main sources. HMGB1 blockade using the anti-HMGB1 antibody HMGB1 box-A (amino-terminal region) and soluble RAGE rescues mice from acute rejection. We therefore studied the release of HMGB1 in co-cultures of porcine aortic endothelial cells (PAEC) and human leukocytes. Human T cells, but not B cells, monocytes or neutrophils, stimulated significant HMGB1 release in culture with PAEC; this activity required cell-cell contact and was dose-dependent, as determined by Western blotting. The released HMGB1 originated from both cell types, as immunofluorescent microscopy showed that it was present in the cytosol of PAEC in contact with T cells, and had disappeared from the T-cell nuclei. These results demonstrate that direct interactions between PAEC and T cells might be a key factor in triggering HMGB1 release, which suggests that HMGB1 is associated with graft rejection in the early phase.


Subject(s)
Endothelium, Vascular/metabolism , HMGB1 Protein/metabolism , T-Lymphocytes/metabolism , Animals , CD3 Complex/analysis , Coculture Techniques , Cytokines/physiology , Graft Rejection/physiopathology , Humans , Inflammation , Leukocytes/metabolism , Swine , Transplantation, Heterologous/immunology
7.
J Vet Med Sci ; 68(8): 865-8, 2006 Aug.
Article in English | MEDLINE | ID: mdl-16953089

ABSTRACT

We investigated the effect of olprinone on canine myocardial pump function and myocardial damage after ischemia-reperfusion injury. Three dogs of the experimental group were given olprinone (Olprinone group) and another 3 dogs were served as control (Intact group). All animals were occluded left anterior descending artery for 60 min, followed by 6 hr of reperfusion. In the experiment, hemodynamics, infarct area, creatine kinase and troponin-I were measured. Olprinone infusion induced significantly high cardiac output value and significantly low values in left ventricular end diastolic pressure and systemic vascular resistance index after reperfusion. Also, olprinone tend to attenuate the infarct area, creatine kinase and troponin-I.


Subject(s)
Dog Diseases/drug therapy , Imidazoles/therapeutic use , Myocardial Reperfusion Injury/veterinary , Phosphodiesterase Inhibitors/therapeutic use , Pyridones/therapeutic use , Animals , Dogs , Imidazoles/pharmacology , Male , Myocardial Reperfusion Injury/drug therapy , Myocardium/pathology , Phosphodiesterase Inhibitors/pharmacology , Pyridones/pharmacology
8.
Histochem Cell Biol ; 126(2): 231-8, 2006 Aug.
Article in English | MEDLINE | ID: mdl-16514547

ABSTRACT

Ghrelin is a novel peptide hormone, originally identified in the rat and human stomach that plays various important roles. In the present study, we report the intra-renal localization of ghrelin in laboratory rodents. Kidneys from 3 month-old mice, rats and hamsters of both sexes were analyzed by immunohistochemistry. Positive signals were clearly observed in the epithelium of the distal tubules, whereas other segments of the nephron or interstitial cells, including juxtaglomerular cells, showed negative reactions. Pre-embedding immunoelectron microscopy revealed positive signals exclusively on the basolateral membrane in the distal tubular cells and in the collecting ducts. In addition, prepro-ghrelin gene expression was assessed by RT-PCR, and the expected 329-bp prepro-ghrelin mRNA was clearly detected in the kidney. On Western blot analysis, although a specific band for ghrelin (3 kDa) was not detected in the kidney, the expected band for prepro-ghrelin (13 kDa) was clearly detected in both the stomach and the kidney. This paper clarified the intra-renal localization of ghrelin.


Subject(s)
Kidney/metabolism , Peptide Hormones/metabolism , Animals , Cell Membrane/metabolism , Cell Membrane/ultrastructure , Cricetinae , Female , Gastric Mucosa/metabolism , Ghrelin , Immunohistochemistry , Kidney Cortex/metabolism , Kidney Cortex/ultrastructure , Kidney Tubules, Collecting/metabolism , Kidney Tubules, Collecting/ultrastructure , Kidney Tubules, Distal/metabolism , Kidney Tubules, Distal/ultrastructure , Male , Mice , Mice, Inbred ICR , Microscopy, Immunoelectron , Rats , Rats, Inbred F344 , Reverse Transcriptase Polymerase Chain Reaction , Stomach/ultrastructure
9.
Exp Anim ; 54(1): 53-60, 2005 Jan.
Article in English | MEDLINE | ID: mdl-15725681

ABSTRACT

The SAMP1/Sku mouse is a substrain of the SAMP1 (senescence-accelerated-mouse prone 1) which exhibits renal mononuclear cell infiltration from a younger age. We hypothesized that this renal characteristic is related to the incidence of tubulointerstitial nephritis (TIN). The purpose of the present study was to evaluate the applicability of the SAMP1/Sku mouse as a murine model for TIN. TIN was experimentally induced by unilateral ureteral obstruction (UUO). The SAMP1/Sku and control ICR of both sexes received either a sham or UUO operation and were sacrificed 7 days after the operation. The kidneys of the mice were observed histopathologically, immunohistochemically and semiquantitatively. UUO kidneys showed mononuclear cell infiltration, tubular atrophy and interstitial fibrosis. In males, semiquantitative scores of mononuclear cell infiltration, tubular atrophy, and F4/80, alpha-smooth muscle actin (alpha-SMA) and transforming growth factor (TGF)-beta1 reactions were significantly higher in SAMP1/Sku than in ICR. Likewise, in females, tubular atrophy and F4/80 reaction scores were significantly higher in SAMP1/Sku than in ICR. In conclusion, induction of TIN damage by UUO was more serious in SAMP1/Sku mice than in ICR. Therefore, we propose that SAMP1/Sku mice, especially male SAMP1/Sku, have congenital risk factors for the development of TIN.


Subject(s)
Disease Models, Animal , Mice, Inbred Strains , Nephritis, Interstitial , Ureteral Obstruction , Actins/metabolism , Animals , Antigens, Differentiation/metabolism , Atrophy , Female , Fibrosis , Immunohistochemistry , Kidney/metabolism , Kidney/pathology , Male , Mice , Necrosis , Nephritis, Interstitial/etiology , Risk Factors , Transforming Growth Factor beta/metabolism , Ureteral Obstruction/complications , Ureteral Obstruction/metabolism , Ureteral Obstruction/pathology
10.
J Anat ; 205(3): 239-46, 2004 Sep.
Article in English | MEDLINE | ID: mdl-15379929

ABSTRACT

Ghrelin is a newly identified gastric peptide hormone that has various important functions, including growth-hormone release and appetite stimulation. Ghrelin-immunoreactive cells (ghrelin cells) are characterized by X-type endocrine cells in the rat stomach. In the present study, we analysed ghrelin cells in fundi of stomach from ICR mice and Syrian hamsters immunohistochemically, immunoelectron microscopically and morphometrically, and compared the results with those from Wistar rats. Immunohistochemistry revealed that ghrelin cells were sparsely distributed in the proper gastric glands in all species. The number of ghrelin cells per unit area in hamsters was significantly lower than that in rats. Immunoelectron microscopy detected ghrelin immunolabelling in granules in the X-type endocrine cells. However, the diameter of granules in the hamsters was significantly smaller than that in the mice and rats. Gastric ghrelin contents were determined by radioimmunoassay, and levels in the hamsters were significantly lower than those in mice and rats. The results from mice were identical to those from rats. In conclusion, gastric ghrelin cells in mice and hamsters are characterized by X-type endocrine cells, as has been observed in rats. However, the data indicated that gastric ghrelin production was lower in hamster than in mouse or rat.


Subject(s)
Gastric Fundus/chemistry , Gastric Fundus/cytology , Peptide Hormones/analysis , Animals , Cricetinae , Ghrelin , Male , Mesocricetus , Mice , Mice, Inbred ICR , Microscopy, Immunoelectron , Radioimmunoassay/methods , Rats , Rats, Wistar , Species Specificity
11.
Exp Anim ; 53(4): 387-90, 2004 Jul.
Article in English | MEDLINE | ID: mdl-15297714

ABSTRACT

The transgenic Tsukuba hypertensive mouse (THM), which expresses the human renin and angiotensinogen genes, develops hypertension secondary to increased renin-angiotensin system activity. The aim of the present study was to assess expression of the renin, cyclooxygenase-2 (COX-2), and neuronal nitric oxide synthase (nNOS) proteins in THM kidneys by immunohistochemical stainings. Renin expression was decreased in the THM kidneys when compared to kidneys from heterozygotes or control mice. Although no differences were observed in nNOS expression, overexpression of the COX-2 protein was observed in the macula densa cells in THM kidneys.


Subject(s)
Hypertension/enzymology , Isoenzymes/analysis , Kidney/enzymology , Nitric Oxide Synthase/analysis , Prostaglandin-Endoperoxide Synthases/analysis , Renin/analysis , Animals , Cyclooxygenase 2 , Disease Models, Animal , Immunohistochemistry , Mice , Mice, Transgenic , Nitric Oxide Synthase Type I
12.
Exp Anim ; 52(4): 335-8, 2003 Jul.
Article in English | MEDLINE | ID: mdl-14562610

ABSTRACT

Acute myocardial ischemia was induced by occluding the LAD in Clawn miniature pigs. Eight pigs (group 1) were subjected to 6 h ischemia and nine pigs (group 2) were subjected to 20 min ischemia, followed by reperfusion for 340 min. Three animals of the group 1 died due to ventricular fibrillation after occlusion and in group 2, four animals died due to the arrhythmia after reperfusion. Though the ischemic area of group 2 (15.6% of the ventricle) was narrower than that of group 1 (21.7%), the survival rate was lower. We supposed that ischemia-reperfusion injuries were strongly connected with the hemodynamics of group 2. Clawn miniature pigs are useful experimental animals for myocardial ischemic researches.


Subject(s)
Hemodynamics/physiology , Myocardial Reperfusion Injury/physiopathology , Swine, Miniature/physiology , Animals , Male
13.
Exp Anim ; 52(4): 349-51, 2003 Jul.
Article in English | MEDLINE | ID: mdl-14562613

ABSTRACT

We have established a new method of anesthesia with nasopharyngeal insufflation for intraoral procedure in rodents. Twelve male Wistar rats weighing 330-390 g were used in this study. Insertion of a feeding tube 1.0 mm in diameter coated with 2% xylocaine jelly was inserted into the nasal cavity approximately 25 mm from the naris, and anesthetization with mixed gas of 100% oxygen with 3-4% enflurane at 0.25-0.5 l/min flow rate was achieved. Using this anesthetic method, a chronic experiment comprising 1-h/day experimental procedure was carried out for 14 days. This method enabled, 1) simple and safe operation of the induction, emergence and anesthetic depth, 2) experimental procedures on the dental/oral region, 3) avoidance of the dyspnea and tachypnea, and 4) avoidance of cumulative effects in daily anesthesia.


Subject(s)
Anesthesia, Inhalation/methods , Insufflation/methods , Nasopharynx/physiology , Rats/physiology , Animals , Male , Rats, Wistar
SELECTION OF CITATIONS
SEARCH DETAIL
...